Financial News
Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
1.705
+0.055
(+3.33%)
Streaming Delayed Price
Updated: 11:42 AM EST, Jan 16, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 230,807 |
| Open | 1.660 |
| Bid (Size) | 1.690 (500) |
| Ask (Size) | 1.720 (5,000) |
| Prev. Close | 1.650 |
| Today's Range | 1.630 - 1.720 |
| 52wk Range | 1.330 - 3.320 |
| Shares Outstanding | 31,056,238 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 20, 2025
12 Health Care Stocks Moving In Monday's After-Market Session ↗
August 18, 2025
These stocks are moving in today's pre-market session ↗
August 18, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 18, 2025
Inhibikase Posts Wider Loss in Q2 ↗
August 14, 2025
Inhibikase Announces Expansion of Senior Leadership Team
February 24, 2025
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 08, 2024
Frequently Asked Questions
Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.705
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 01/16/26 11:42 AM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 52.95M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 53M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
